In recent years, the clinical availability of scanners for integrated positron emission tomography (PET) and magnetic resonance imaging (MRI) has enabled the practical potential of multimodal, combined metabolic-receptor, anatomical, and functional imaging to be explored. The present systematic review and meta-analysis summarize the diagnostic information provided by PET/MRI in patients with prostate cancer (PCa).
PET/MRI in prostate cancer: a systematic review and meta-analysis
Evangelista, Laura
;Zattoni, Fabio;Cassarino, Gianluca;Artioli, Paolo;Cecchin, Diego;Dal Moro, Fabrizio;Zucchetta, Pietro
2021
Abstract
In recent years, the clinical availability of scanners for integrated positron emission tomography (PET) and magnetic resonance imaging (MRI) has enabled the practical potential of multimodal, combined metabolic-receptor, anatomical, and functional imaging to be explored. The present systematic review and meta-analysis summarize the diagnostic information provided by PET/MRI in patients with prostate cancer (PCa).File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
unpaywall-bitstream--541356355.pdf
accesso aperto
Tipologia:
Published (publisher's version)
Licenza:
Creative commons
Dimensione
532.75 kB
Formato
Adobe PDF
|
532.75 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.